No Fooling: Japanese User Fees, Revised Reimbursement Rates Debut April 1
This article was originally published in The Gray Sheet
Executive Summary
New product applications should be assigned to one team of reviewers throughout the Japanese review process, according to AdvaMed
You may also be interested in...
Japan’s ’05 Reforms Will Increase Efficiency, Reflect ’04 Industry Effort
Faster reviews of low-risk medical devices in Japan are on the horizon as the fledgling Pharmaceutical & Medical Devices Agency prepares to implement new review processes, effective April 1
Japan’s ’05 Reforms Will Increase Efficiency, Reflect ’04 Industry Effort
Faster reviews of low-risk medical devices in Japan are on the horizon as the fledgling Pharmaceutical & Medical Devices Agency prepares to implement new review processes, effective April 1
New Japanese Agency Will Accept STED; MHLW Retains Payment Control
Japan's Ministry of Health, Labor & Welfare will accept medical device applications in the STED format beginning next April, according to the U.S. Trade Representative's "1Third Report To The Leaders On The U.S.-Japan Regulatory Reform And Competition Policy Initiative," released June 8